Hyperhomocysteinemia: A risk factor for central retinal vein occlusion

American Journal of Ophthalmology

Volumn 129, Issue 5, 2000, Pages 640-644

  Vine, Andrew K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 0034126184     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00476-6     Document Type: Article

References (45)

1. Mudd S.H., Levy H.L., Skovby F. Disorders of transsulfuration. Scriver C.R., Beaudet A.L., Sly W.S., et al. The metabolic and molecular bases of inherited disease. 1995;1279-1327 McGraw-Hill, New York.
2. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease a common mutation in methylenetetrahydrofolate reductase . Nat Genet. 10:1995;111-113.
3. Nygård O., Refsum H., Ueland P.M., et al. Major lifestyle determinants of plasma homocysteine distribution the Hordaland Homocysteine Study . Am J Clin Nutr. 67:1998;263-270.
4. Morgan S.L., Baggott J.E., Lee J.Y., et al. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low dose methotrexate therapy for rheumatoid arthritis implications for cardiovascular disease prevention . J Rheumatol. 25:1998;441-446.
5. Refsum H., Ueland P.M., Nygård O., et al. Homocysteine and cardiovascular disease. Ann Rev Med. 49:1998;31-62.
6. Selhub J., Jacques P.F., Wilson P.W., et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:1993;2693-2698.
7. McCully K.S., Wilson R.B. Homocysteine theory of arteriosclerosis. Atherosclerosis. 22:1975;215-227.
8. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia an independent risk factor for vascular disease . N Engl J Med. 324:1991;1149-1155.
9. Stampfer M.J., Malinow M.R., Willett W.C., et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA. 268:1992;877-881.
10. Perry I.J., Refsum H., Morris R.W., et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1995;1395-1398.
11. Nygård O., Nordrehaug J.E., Refsum H., et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1997;230-236.
12. Wald N.J., Watt H.C., Law M.R., et al. Homocysteine and ischemic heart disease results of a prospective study with implications regarding prevention . Arch Intern Med. 158:1998;862-867.
13. Malinow M.R., Nieto F.J., Szklo M., et al. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults the Atherosclerosis Risk in Communities Study . Circulation. 87:1993;1107-1113.
14. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease the European Concerted Action Project . JAMA. 277:1997;1775-1781.
15. den Heijer M., Blom H.J., Gerrits W.B.J., et al. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet. 345:1995;882-885.
16. Simioni P., Prandoni P., Burlina A., et al. Hyperhomocysteinemia and deep-vein thrombosis. Thromb Haemost. 76:1996;883-886.
17. den Heijer M., Koster T., Blom H.J., et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 334:1996;759-762.
18. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 114:1996;545-554.
19. Ubbink J.B., Vermaak W.J.H., van der Merwe A., et al. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta. 207:1992;119-128.
20. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion the Central Vein Occlusion Study Group N Report . Ophthalmology. 102:1995;1434-1444.
21. Ueland P.M., Refsum H., Stabler S.P., et al. Total homocysteine in plasma or serum methods and clinical applications . Clin Chem. 39:1993;1764-1779.
22. Gart J.J. The comparison of proportions a review of significance tests, confidence intervals and adjustments for stratification . Int Stat Rev. 39:1971;148-169.
23. Wenzler E.M., Rademakers A.J.J.M., Boers G.H.J., et al. Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol. 115:1993;162-167.
24. Biousse V., Newman N.J., Sternberg P. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocysteinemia. Am J Ophthalmol. 124:1997;257-260.
25. Loewenstein A., Winder A., Goldstein M., et al. Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. Am J Ophthalmol. 124:1997;840-841.
26. De Bruijne E.L.E., Keulen de Vos G.H.J.C., Ouwendijk R.J.T. Ocular venous occlusion and hyperhomocysteinemia. [letter] Ann Intern Med. 130:1999;78.
27. Brattström L., Israelsson B., Norrving B., et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease effects of pyridoxine and folic acid treatment . Atherosclerosis. 81:1990;51-60.
28. Boushey C.J., Beresford S.A.A., Omenn G.S., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease probable benefits of increasing folic acid intakes . JAMA. 274:1995;1049-1057.
29. Green W.R., Chan C.C., Hutchins G.M., et al. Central retinal vein occlusion a prospective histopathologic study of 29 eyes in 28 cases . Trans Am Ophthalmol Soc. 79:1981;371-422.
30. Greaves M. Aging and the pathogenesis of retinal vein thrombosis. Br J Ophthalmol. 81:1997;810-811.
31. Sutton-Tyrell K., Bostom A., Selhub J., et al. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation. 96:1997;1745-1749.
32. Elman M.J., Bhatt A.K., Quinlan P.M., et al. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology. 97:1990;1543-1548.
33. Nygård O., Vollset S.E., Refsum H., et al. Total plasma homocysteine and cardiovascular risk profile the Hordaland Homocysteine Study . JAMA. 274:1995;1526-1533.
34. Guttormsen A.B., Schneede J., Fiskerstrand T., et al. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr. 124:1994;1934-1941.
35. Ma J., Stampfer M.J., Hennekens C.H., et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 94:1996;2410-2416.
36. 6 concentrations risk factors for stroke, peripheral vascular disease, and coronary artery disease . Circulation. 97:1998;437-443.
37. 6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 279:1998;359-364.
38. Morrison H.I., Schaubel D., Desmeules M., et al. Serum folate and risk of fatal coronary heart disease. JAMA. 275:1996;1893-1896.
39. 12, and folate . Am J Epidemiol. 143:1996;845-859.
40. 6 and risk of myocardial infarction in US physicians. J Am Coll Nutr. 15:1996;136-143.
41. Omenn G.S., Beresford S.A.A., Motulsky A.G. Preventing coronary heart disease B vitamins and homocysteine . Circulation. 97:1998;421-424.
42. Selhub J., Jacques P.F., Bostom A.G., et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 332:1995;286-291.
43. Jacob R.A., Wu M., Henning S.M., et al. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J Nutr. 124:1994;1072-1080.
44. Stampfer M.J., Willett W.C. Homocysteine and marginal vitamin deficiency. JAMA. 270:1993;2726-2727.
45. Oakley G.P. Eat right and take a multivitamin. N Engl J Med. 338:1998;1060-1061.